rational
activ
vasoconstrict
prolif
fibrot
axi
renin
angiotensin
system
angiotensinconvert
enzym
ace
angiotensin
ang
iiangii
type
receptor
implic
pathophysiolog
pulmonari
fibrosi
pf
pulmonari
hypertens
ph
recent
discoveri
counterregulatori
axi
renin
angiotensin
system
compos
ang
ma
led
us
examin
role
vasoprotect
axi
disord
object
hypothes
ang
treatment
would
exert
protect
effect
pf
ph
method
lentivir
packag
ang
fusion
gene
cdna
intratrach
administ
lung
male
spragu
dawley
rat
two
week
gene
transfer
anim
receiv
bleomycin
mgkg
subsequ
studi
anim
administ
monocrotalin
mct
mgkg
measur
main
result
pf
studi
bleomycin
administr
result
signific
increas
right
ventricular
systol
pressur
associ
develop
right
ventricular
hypertrophi
lung
anim
also
exhibit
excess
collagen
deposit
decreas
express
ace
increas
mrna
level
transform
growth
factor
b
proinflammatori
cytokin
increas
protein
level
r
overexpress
ang
significantli
prevent
abovement
pathophysiolog
condit
similar
protect
effect
also
obtain
overexpress
ph
studi
rat
inject
mct
develop
elev
right
ventricular
systol
pressur
right
ventricular
hypertrophi
right
ventricular
fibrosi
pulmonari
vascular
remodel
attenu
ang
overexpress
blockad
ma
receptor
abolish
benefici
effect
ang
mctinduc
ph
conclus
observ
demonstr
cardiopulmonari
protect
role
ma
axi
treatment
lung
disord
pulmonari
fibrosi
pf
fatal
lung
diseas
unknown
caus
diseas
character
progress
scar
lung
tissu
accompani
fibroblast
prolifer
excess
accumul
matrix
protein
abnorm
alveolar
structur
lead
loss
lung
function
ultim
respiratori
failur
current
treatment
antiinflammatori
immunosuppress
antifibrot
agent
shown
promis
result
abat
progress
diseas
improv
qualiti
life
thu
becom
essenti
better
understand
diseas
pathophysiolog
identifi
novel
therapeut
targetsag
treatment
pf
experiment
clinic
evid
indic
activ
pulmonari
renin
angiotensin
system
ra
involv
pathophysiolog
diseas
polymorph
angiotensinogen
agt
gene
associ
progress
idiopath
pulmonari
fibrosi
agt
found
one
overexpress
gene
patient
pf
angiotensin
ii
ang
ii
shown
stimul
cell
growth
prolifer
lung
fibroblast
ang
ii
known
upregul
express
transform
growth
factorb
tgfb
central
player
fibrogenesi
ang
iiinduc
tgfb
gener
associ
differenti
fibroblast
myofibroblast
dramat
enhanc
extracellular
matrix
protein
deposit
ang
ii
involv
lung
inflamm
gener
reactiv
oxygen
speci
releas
proinflammatori
cytokin
ang
ii
shown
induc
alveolar
epitheli
cell
apoptosi
believ
initi
fibrot
process
ang
ii
also
involv
promot
procoagulatori
effect
activ
plasminogen
activ
anoth
lung
diseas
close
associ
alter
ra
pulmonari
hypertens
ph
polymorph
gene
encod
compon
ra
agt
angiotensinconvert
enzym
ace
ang
ii
type
receptor
r
link
develop
ph
local
product
ang
ii
ace
stimul
growth
smooth
muscl
cell
arteri
wall
caus
maladapt
chang
function
pulmonari
vasculatur
result
develop
ph
evid
modul
compon
ra
appear
viabl
therapeut
strategi
treatment
lung
diseas
pf
ph
howev
direct
target
ra
compon
lung
disord
use
ace
inhibitor
r
blocker
produc
mix
result
anim
model
human
nevertheless
recent
discoveri
homolog
ace
call
enzymat
product
angiotensin
ang
offer
altern
pathway
regul
intrapulmonari
compon
ra
produc
benefici
effect
ang
heptapeptid
counteract
mani
detriment
effect
ang
ii
includ
heart
failur
kidney
diseas
diabet
complic
howev
role
ang
pulmonari
disord
especi
pf
ph
yet
investig
ang
peptid
undergo
rapid
proteolyt
degrad
circul
decid
adopt
novel
strategi
overexpress
peptid
local
lung
tissu
lentiviralmedi
gene
deliveri
approach
thu
studi
propos
lentiviralmedi
pulmonari
overexpress
ang
exert
cardiopulmonari
benefici
effect
two
experiment
model
lung
disord
pf
ph
result
studi
previous
report
form
abstract
bleomycin
sulfat
purchas
calbiocem
lab
san
diego
ca
mous
monoclon
antibactin
antibodi
monocrotalin
mct
smooth
muscl
actin
clone
purchas
sigmaaldrich
st
loui
mo
r
rabbit
polyclon
antibodi
ace
rabbit
polyclon
antibodi
procur
santa
cruz
biotechnolog
santa
cruz
ca
alzet
osmot
pump
model
purchas
durect
corpor
cupertino
ca
masreceptor
antagonist
purchas
bachem
torranc
ca
fiveweekold
male
spragu
dawley
rat
use
studi
anim
hous
temperaturecontrol
room
maintain
light
dark
cycl
free
access
water
food
procedur
involv
experiment
anim
approv
institut
anim
care
use
committe
univers
florida
compli
nation
institut
health
guidelin
gene
deliveri
lung
rat
anesthet
isofluran
midlin
incis
made
expos
trachea
empti
viru
control
lentiang
viral
particl
tu
ml
phosphatebuff
salin
inject
trachea
follow
ml
air
enhanc
spread
viru
rat
lung
two
week
lentivir
treatment
anim
subject
bleomycin
monocrotalin
administr
anim
influenc
isofluran
anesthesia
receiv
singl
intratrach
instil
mgkg
dose
bleomycin
sulfat
ml
steril
salin
solut
instil
end
expir
liquid
immedi
follow
ml
air
increas
deliveri
distal
airway
control
anim
receiv
equal
volum
steril
salin
ph
induc
singl
subcutan
inject
mct
mgkg
control
rat
receiv
salin
ml
subcutan
time
mct
administr
subset
anim
implant
alzet
miniosmot
pump
model
contain
ma
antagonist
infus
rate
mgd
mgml
stock
solut
day
weekli
system
blood
pressur
measur
consciou
rat
use
noninvas
tailcuff
method
narco
biosystem
austin
tx
describ
elsewher
measur
right
ventricular
systol
pressur
rvsp
rat
anesthet
mixtur
ketamin
mgkg
subcutan
xylazin
mgkg
subcutan
place
supin
posit
breath
room
air
rvsp
measur
use
silast
cathet
insert
right
descend
jugular
vein
forward
rv
data
record
stabil
trace
use
liquid
pressur
transduc
interfac
powerlab
ad
instrument
colorado
spring
co
signal
transduct
unit
waveform
use
confirm
posit
cathet
rv
data
analyz
use
chart
program
suppli
powerlab
system
rvsp
measur
rat
kill
heart
lung
harvest
lung
collagen
deposit
estim
measur
hydroxylprolin
content
briefli
frozen
lung
tissu
homogen
ml
glacial
acet
acid
moll
dri
speed
vacuum
dri
sampl
weigh
dissolv
ml
n
hcl
hydrolyz
overnight
acid
hydrolys
standard
appli
elisa
plate
along
citricacet
buffer
chloramin
solut
minut
ehrlich
solut
ad
incub
minut
reaction
product
read
nm
solut
mgml
hydroxyprolin
sigma
st
loui
mo
use
construct
standard
curv
data
present
mean
sem
statist
differ
evalu
either
oneway
twoway
analysi
varianc
wherev
applic
follow
newmankeul
test
p
valu
less
consid
statist
signific
product
ang
lentivir
particl
determin
transduct
effici
lung
lentiviru
cardiac
hypertrophi
quantit
realtim
revers
transcriptionpolymeras
chain
reaction
western
blot
analysi
electron
spin
reson
spectroscopi
describ
onlin
data
supplement
infect
cardiac
myoblast
multipl
infect
lentiang
fusion
protein
result
robust
express
isotyp
figur
furthermor
vivo
experi
also
demonstr
increas
level
ang
peptid
lentiang
infect
rat
lung
compar
control
anim
figur
data
establish
lentiang
activ
effect
secret
ang
secret
ang
present
week
administr
viral
vectorcontain
transgen
efficaci
murin
mrna
detect
lung
rat
treat
also
previous
report
occur
mice
tracheal
induc
murin
express
control
anim
data
shown
patholog
score
hydroxyprolin
content
lung
tissu
bleomycin
administr
lung
section
differ
treatment
group
stain
hematoxylineosin
repres
section
shown
figur
ashcroft
score
determin
five
differ
nonoverlap
field
lung
section
differ
treatment
group
describ
previous
mean
group
result
demonstr
higher
score
bleomycin
alon
group
compar
control
anim
indic
fibrot
respons
bleomycin
administr
howev
anim
treat
either
ang
show
significantli
lower
score
demonstr
protect
effect
develop
bleomycininduc
fibrosi
result
summar
figur
along
similar
line
increas
lung
collagen
accumul
assess
measur
lung
hydroxyprolin
observ
bleomycin
alon
group
significantli
reduc
either
ang
overexpress
figur
effect
differ
treatment
lung
mrna
express
tgfb
figur
demonstr
express
tgfb
significantli
elev
bleomycin
group
compar
normal
lung
tgfb
express
significantli
suppress
either
ang
overexpress
hand
mrna
level
endogen
membranebound
enzym
significantli
decreas
bleomycintr
anim
figur
decreas
complet
prevent
overexpress
ang
treatment
result
intermedi
respons
anim
differ
either
control
anim
bleomycintr
group
western
analysi
compar
quantif
ace
bleomycin
studi
bleomycin
administr
significantli
decreas
ace
protein
level
decreas
prevent
overexpress
either
ang
figur
contrast
bleomycin
treatment
result
signific
increas
lung
protein
compar
control
anim
increas
significantli
attenu
ang
overexpress
overexpress
figur
prevent
mctinduc
ph
associ
cardiopulmonari
remodel
ang
singl
subcutan
administr
mct
rat
result
robust
increas
rvsp
week
mm
hg
control
vs
mm
hg
mct
p
n
figur
overexpress
ang
significantli
attenu
mctinduc
elev
rvsp
mm
hg
p
n
mctchalleng
anim
also
develop
rvh
measur
right
ventricleleft
ventricl
septum
ratio
control
vs
mct
p
n
figur
likewis
prevent
overexpress
ang
p
n
empti
viru
without
effect
paramet
assess
furthermor
mct
treatment
result
increas
medial
wall
thick
also
significantli
attenu
ang
overexpress
figur
rat
treat
mct
exhibit
increas
interstiti
right
ventricular
fibrosi
evalu
percent
fibrot
area
effect
ang
overexpress
mctinduc
lung
ra
inflammatori
cytokin
cytokin
shown
play
key
role
pathophysiolog
ph
evalu
effect
ang
overexpress
inflammatori
cytokin
oxid
stress
tabl
summar
quantit
measur
mrna
inflammatori
cytokin
mct
mct
ang
treat
rat
mct
treatment
result
signific
increas
mrna
level
proinflammatori
cytokin
tnfa
subunit
nadph
oxidas
tend
increas
mct
treatment
increas
statist
signific
tabl
ang
overexpress
mctchalleng
rat
result
revers
pattern
decreas
level
tnfa
contrast
signific
increas
antiinflammatori
cytokin
mcttreat
rat
overexpress
ang
electron
spin
reson
spectroscopi
reveal
increas
oxid
stress
pulmonari
arteri
lung
mctchalleng
anim
significantli
attenu
ang
overexpress
figur
lung
ra
mct
treatment
result
increas
ace
mrna
level
significantli
decreas
overexpress
ang
level
mrna
tend
increas
mct
treatment
possibl
compensatori
manner
howev
increas
significantli
higher
control
anim
mct
ang
group
signific
find
studi
overexpress
enzym
gener
ang
ang
target
gene
transfer
protect
lung
lung
fibrosi
pulmonari
hypertens
knowledg
first
studi
report
benefici
effect
ang
lung
diseas
use
novel
lentiviralmedi
gene
deliveri
approach
ang
gene
product
enzymat
breakdown
metabolit
ang
ii
devis
synthet
gene
ang
packag
lentiviru
current
studi
endotrach
instil
bleomycin
evok
sever
fibrot
respons
character
accumul
interstiti
lung
collagen
collagen
deposit
significantli
decreas
overexpress
ang
report
increas
lung
r
level
may
consider
contribut
fibrot
process
collagensynthesi
activ
fibroblast
enhanc
respons
r
stimul
lung
r
significantli
increas
bleomycin
administr
consist
previou
report
effect
bleomycin
attenu
pulmonari
overexpress
ang
downregul
r
ang
report
tissu
howev
reduct
lung
r
protein
level
observ
treatment
group
specul
overexpress
may
either
inhibit
compon
r
signal
pathway
stimul
degrad
collagen
bring
benefici
antifibrot
effect
lung
protein
analysi
reveal
decreas
ace
level
bleomycintr
rat
decreas
pulmonari
ace
activ
associ
bleomycin
injuri
report
anim
human
studi
confirm
current
find
mrna
level
also
significantli
lower
bleomycin
treatment
also
agreement
publish
data
accordingli
observ
decreas
ace
predominantli
express
endotheli
cell
may
attribut
endotheli
injuri
fact
endothelium
identifi
primari
site
injuri
bleomycin
toxic
tgfb
import
cytokin
play
key
role
fibrogenesi
vitro
vivo
studi
demonstr
increas
tgfb
level
bleomycin
treatment
line
studi
also
observ
increas
lung
mrna
level
profibrot
cytokin
bleomycin
instil
significantli
reduc
overexpress
ang
other
demonstr
ang
reduc
tgfb
level
fibroblast
cell
cultur
experi
clinic
presenc
ph
secondari
fibrot
lung
diseas
call
cor
pulmonal
indic
poor
prognosi
compromis
cardiac
function
studi
detect
pulmonari
hypertens
rvh
bleomycin
administr
howev
treatment
ang
prevent
develop
ph
rvh
find
protect
effect
ang
overexpress
also
confer
similar
benefici
effect
possibl
mediat
via
gener
ang
conceiv
protect
effect
ang
heart
may
secondari
reduct
lung
fibrosi
howev
also
possibl
ang
may
direct
effect
heart
previous
report
direct
protect
effect
overexpress
ang
treatment
heart
remodel
also
demonstr
lentivir
administr
mcttreat
mice
prevent
develop
pulmonari
hypertens
cardiac
remodel
likewis
similar
find
observ
synthet
activ
enzym
mct
model
ph
collect
result
result
current
pf
studi
demonstr
benefici
effect
ang
pulmonari
pressur
encourag
us
perform
subsequ
experi
determin
whether
ang
overexpress
would
prevent
develop
ph
monocrotalin
model
four
week
mct
treatment
result
signific
increas
rvsp
accompani
cardiac
remodel
term
develop
rvh
fibrosi
overexpress
ang
induct
ph
result
prevent
elev
pressur
attenu
remodel
effect
heart
prevent
rvh
fibrosi
ang
offer
cardioprotect
role
pathobiolog
ph
structur
chang
pulmonari
vasculatur
character
medial
wall
thicken
pulmonari
arteriol
promin
featur
human
ph
thicken
pulmonari
arteriol
increas
pulmonari
arteri
resist
contribut
elev
pressur
mctchalleng
anim
exhibit
mark
increas
wall
thick
pulmonari
resist
vessel
overexpress
ang
result
nearnorm
vessel
morpholog
like
inhibit
vascular
remodel
direct
effect
ang
previou
find
demonstr
antiprolif
properti
peptid
vascular
smooth
muscl
cell
ang
believ
mediat
biolog
effect
interact
g
proteincoupl
receptor
ma
express
ma
observ
lung
tissu
receptor
block
use
specif
potent
antagonist
coadministr
abolish
benefici
effect
ang
strongli
suggest
protect
role
ang
ma
axi
ph
increas
express
proinflammatori
cytokin
characterist
hallmark
ph
line
find
elev
lung
mrna
level
proinflammatori
cytokin
observ
mct
alon
group
overexpress
ang
appear
prevent
increas
mrna
level
proinflammatori
cytokin
tnfa
produc
increas
antiinflammatori
cytokin
recent
demonstr
xnt
activ
also
increas
lung
express
mct
model
ph
alter
inflammatori
system
peptid
renin
angiotensin
system
signific
antiinflammatori
therapi
current
investig
treatment
ph
recent
report
ito
colleagu
shown
overexpress
exert
benefici
effect
ph
one
reason
observ
favor
chang
cytokin
level
ang
overexpress
may
due
modul
intrapulmonari
ra
known
potent
regul
cytokin
inflamm
howev
direct
effect
ang
immunomodulatori
system
may
rule
ang
treatment
prevent
mctinduc
increas
ace
mrna
level
significantli
upregul
level
unexpect
observ
express
increas
overexpress
ang
although
similar
increas
express
also
observ
xnt
treatment
also
cardiacspecif
overexpress
ang
result
increas
level
heart
unpublish
data
pure
specul
posit
feedback
mechan
may
respons
observ
phenomenon
nevertheless
explan
clearli
warrant
evalu
lung
overexpress
ang
advers
affect
basal
system
blood
pressur
clinic
lack
effect
system
blood
pressur
becom
relev
system
hypotens
could
worsen
prognosi
patient
compromis
cardiopulmonari
function
studi
kuba
colleagu
demonstr
benefici
role
acut
lung
injuri
importantli
sever
acut
respiratori
syndromecorona
viru
infect
similarli
studi
li
colleagu
show
protect
downregul
experiment
human
lung
fibrosi
also
studi
laboratori
demonstr
overexpress
activ
prevent
develop
ph
relat
cardiac
pathophysiolog
present
studi
extend
find
earlier
experi
suggest
benefici
effect
overexpressionactiv
like
mediat
via
gener
ang
peptid
turn
stimul
ma
receptor
bring
protect
taken
togeth
previou
current
studi
indic
target
pulmonari
ma
axi
could
provid
novel
therapeut
strategi
treatment
lung
diseas
particularli
involv
pulmonari
fibrosi
pulmonari
hypertens
find
suggest
ang
mediat
protect
effect
differ
pathway
appear
effect
therapeut
effect
may
accomplish
dual
treatment
regimen
demonstr
angiotensin
cardiopulmonari
protect
role
recogn
anim
model
lung
fibrosi
pulmonari
hypertens
clinic
trial
ang
current
underway
treat
cancer
patient
use
ang
new
therapi
pulmonari
diseas
lung
fibrosishypertens
might
plausibl
medic
use
bleomycin
tumor
suppress
limit
due
induct
pf
thu
possibl
combin
therapi
ang
enhanc
therapeut
efficaci
bleomycin
prevent
pulmonari
toxic
author
disclosur
vs
financi
relationship
commerci
entiti
interest
subject
manuscript
ajf
financi
relationship
commerci
entiti
interest
subject
manuscript
yq
financi
relationship
commerci
entiti
interest
subject
manuscript
raf
financi
relationship
commerci
entiti
interest
subject
manuscript
cd
financi
relationship
commerci
entiti
interest
subject
manuscript
ad
financi
relationship
commerci
entiti
interest
subject
manuscript
jyj
financi
relationship
commerci
entiti
interest
subject
manuscript
ss
financi
relationship
commerci
entiti
interest
subject
manuscript
nm
financi
relationship
commerci
entiti
interest
subject
manuscript
dp
financi
relationship
commerci
entiti
interest
subject
manuscript
csv
financi
relationship
commerci
entiti
interest
subject
manuscript
jf
financi
relationship
commerci
entiti
interest
subject
manuscript
tr
receiv
lectur
fee
novarti
receiv
industrysponsor
grant
pfizer
receiv
sponsor
grant
canadian
institut
health
research
ra
receiv
industrysponsor
grant
daiichisankyo
jmp
financi
relationship
commerci
entiti
interest
subject
manuscript
mkr
receiv
sponsor
grant
nih
mjk
receiv
sponsor
grant
american
heart
associ
nih
